Nimish P Shah

10% Owner; Director · 2 filings · Latest: Jun 9, 2026

Apogee Therapeutics, Inc.

KalVista Pharmaceuticals, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
KALV	Nimish P Shah	10% Owner	Mar 26, 2026	Sale	$18.28	39,986	$730.8K	5,089,354	Mar 27 9:50 PM
KALV	Nimish P Shah	10% Owner	Mar 25, 2026	Sale	$16.95	174,645	$3.0M	5,129,340	Mar 27 9:50 PM